These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 50855)

  • 1. Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test.
    Shelton JB; Potter CW; Carr I
    Br J Cancer; 1975 May; 31(5):528-34. PubMed ID: 50855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity to encephalitogenic factor as measured by macrophage migration inhibition during tumour induction and growth.
    Flavell DJ; Goepel J; Potter CW; Carr I
    Br J Cancer; 1978 May; 37(5):818-26. PubMed ID: 77674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.
    Flavell DJ; Potter CW
    Br J Cancer; 1978 Jan; 37(1):15-22. PubMed ID: 74259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immunity to human basic myelin protein in women with dysplasia and carcinoma in situ of the cervix.
    Singer A; Shelton J; Hill S; Potter C
    Br J Obstet Gynaecol; 1975 Oct; 82(10):820-5. PubMed ID: 53067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
    Cerni CH; Micksche M
    Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
    Sheremata W; Eylar EH; Cosgrove JB
    J Neurol Sci; 1977 Jun; 32(2):255-63. PubMed ID: 69018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.
    Flavell DJ; Singer A; Potter CW
    Br J Cancer; 1978 Sep; 38(3):396-400. PubMed ID: 81675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological cross-reactivity between acid extracts of myelin, liver and neoplastic tissues: studies in immunized guinea-pigs.
    Flavell DJ; Goepel J; Wilson AP; Potter CW
    Br J Cancer; 1979 Sep; 40(3):424-36. PubMed ID: 92328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of cellular sensitization to myelin antigens in multiple sclerosis. Dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus monkeys.
    Colby-Germinario SP; Sheremata W; Bain B; Eylar EH
    J Neurol Sci; 1977 Aug; 33(1-2):111-29. PubMed ID: 71338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-association and soluble antigen.
    Steinman L; Cohen IR; Teitelbaum D; Arnon R
    Nature; 1977 Jan; 265(5590):173-5. PubMed ID: 64932
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular and humoral responses to myelin basic protein in multiple sclerosis: a dichotomy.
    Sheremata W; Woods DD; Moscarello MA
    Adv Exp Med Biol; 1978; 100():501-11. PubMed ID: 80948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune response against myelin basic protein in two strains of rat with different genetic capacity to develop experimental allergic encephalomyelitis.
    McFarlin DE; Hsu SC; Slemenda SB; Chou FC; Kibler RF
    J Exp Med; 1975 Jan; 141(1):72-81. PubMed ID: 46914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
    Rahi AH; Otiko G; Winder AF
    Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunity to encephalitogenic peptide in tumour-bearing mice.
    Yong WK; Halliday WJ
    Br J Cancer; 1982 May; 45(5):754-61. PubMed ID: 6177329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
    Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
    Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A direct macrophage migration inhibition test applied in man.
    Teelken AW; Minderhoud JM
    Clin Exp Immunol; 1976 Apr; 24(1):26-32. PubMed ID: 59649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitization against the antigens of the brain after experimental vaccinia infection. I. Evidence for cell-mediated immune response to brain-antigens (author's transl)].
    Huber HC; Zinn KH; Hochstein-Mintzel V; Simon J; Stickl H
    Zentralbl Bakteriol Orig A; 1975 Jun; 232(1):1-7. PubMed ID: 51549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal immune response to brain tissue antigen in the syndrome of autism.
    Weizman A; Weizman R; Szekely GA; Wijsenbeek H; Livni E
    Am J Psychiatry; 1982 Nov; 139(11):1462-5. PubMed ID: 6182806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity to bovine myelin basic protein in rats bearing malignant fibrous histiocytoma.
    Ribeiro RA; Lopes-Alberto F; De-Lucca FL
    Braz J Med Biol Res; 1989; 22(6):721-4. PubMed ID: 2482789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage electrophoretic mobility (MEM) with myelin basic protein.
    Rawlins GA; Wood JM; Bagshawe KD
    Br J Cancer; 1976 Dec; 34(6):613-8. PubMed ID: 1008988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.